Uric AcidNCT06837545
Uric Acid and Surgical Prognosis
An observational study of Uric Acid, run by Asan Medical Center at 1 site in South Korea.
Trial summary
Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Uric Acid
- How many people
- 309,353 participants
- Where
- 1 siteSouth Korea
- Study dates
- 30 Jul 2024to 2 Jan 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population includes adult patients aged 18 years or older who underwent non-cardiac surgeries at a tertiary hospital. Patients with emergency surgeries, pregnancy, cadavers, and incomplete data with missing preoperative uric acid levels, or missing follow-up information were excluded from the analysis. The study focuses on evaluating the impact of preoperative uric acid on postoperative outcomes, including mortality and morbidities.
Who may be able to join
- Patients aged 18 years or older
- Patients who underwent non-cardiac surgery
Who cannot join
- Emergency surgery
- Pregnancy
- Cadavers
- Patients with missing preoperative SUA values or no follow-up after surgery
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sex-specific Associations of Preoperative Serum Uric Acid Levels with Mortality and Morbidity in Non-cardiac Surgeries
Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery.
Read the detailed description
Preoperative SUA levels demonstrate a nonlinear, sex-specific relationship with postoperative outcomes in non-cardiac surgery.
- Conditions
- Uric Acid
- Being tested
- No Intervention (Observational Study)
- Keywords
- Uric Acid, Mortality, Surgical Prognosis, Acute Kidney Injury
- Medical subject headings
- Acute Kidney Injury
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No Intervention (Observational Study)Other
This study is an observational analysis of preoperative serum uric acid levels and their association with postoperative outcomes. No intervention was administered."
What is being measured
The primary outcome is the main question the study is designed to answer.
30-day postoperative mortality
The primary outcome measure is the incidence of 30-day postoperative mortality in patients undergoing non-cardiac surgeries. Mortality is defined as death occurring within 30 days following the surgery.
Measured: 30 days post-surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2025
- Study start30 Jul 2024
- Primary completion20 Dec 2024
- Study completion2 Jan 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Uric AcidStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 309,353 participants (actual)
Sponsor and investigators
- Lead sponsor
- Asan Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ji-Hoon Sim, Asan Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06837545
- Sponsor's protocol ID
- AMC (2024-1090)
- Status last verified
- Feb 2025
- First submitted
- 15 Feb 2025
- Last updated
- 20 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No: The dataset used and/or analyzed during the current study is available from the corresponding author upon reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 20 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sex-specific Associations of Preoperative Serum Uric Acid Levels with Mortality and Morbidity in Non-cardiac Surgeries
- ClinicalTrials.gov ID
- NCT06837545
- Acronym / sponsor ID
- AMC (2024-1090)
- Conditions
- Uric Acid
- Keywords
- Uric Acid, Mortality, Surgical Prognosis, Acute Kidney Injury
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 309,353 participants (actual)
- Lead sponsor
- Asan Medical CenterUniversity, hospital or other
- Study start
- 30 Jul 2024 (actual)
- Primary completion
- 20 Dec 2024 (actual)
- Study completion
- 2 Jan 2025 (actual)
- First posted
- 20 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery.
Detailed description
Preoperative SUA levels demonstrate a nonlinear, sex-specific relationship with postoperative outcomes in non-cardiac surgery.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population includes adult patients aged 18 years or older who underwent non-cardiac surgeries at a tertiary hospital. Patients with emergency surgeries, pregnancy, cadavers, and incomplete data with missing preoperative uric acid levels, or missing follow-up information were excluded from the analysis. The study focuses on evaluating the impact of preoperative uric acid on postoperative outcomes, including mortality and morbidities.
Key inclusion criteria (2 listed)
- Patients aged 18 years or older
- Patients who underwent non-cardiac surgery
Key exclusion criteria (4 listed)
- Emergency surgery
- Pregnancy
- Cadavers
- Patients with missing preoperative SUA values or no follow-up after surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No Intervention (Observational Study)This study is an observational analysis of preoperative serum uric acid levels and their association with postoperative outcomes. No intervention was administered." | Other | – |
Primary outcome
30-day postoperative mortality
Time frame: 30 days post-surgery
The primary outcome measure is the incidence of 30-day postoperative mortality in patients undergoing non-cardiac surgeries. Mortality is defined as death occurring within 30 days following the surgery.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Feb 2025.
- Individual participant dataSharing planned: No. The dataset used and/or analyzed during the current study is available from the corresponding author upon reasonable request.
Related trials for Uric Acid
Not yet recruitingPhase 3
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Gout
Gout Disease
Not yet recruitingObservational study
Dynamic Inflammatory Changes and Nutritional Risk Scores in ICU Patients Aged 65 Years and Older
Critical Illness, Geriatric Patient
Enrolling by invitation
The Remote Monitoring of Gout Study
Gout Initiating Urate-loweringUrate-lowering Therapy
Recruiting
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Gout, Gouty Arthritis
Active, not recruiting
Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy Subjects
Healthy, Hyperuricemia, Gout
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Uric Acid, run by Asan Medical Center at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
30-day postoperative mortality (time frame: 30 days post-surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2025.